The SOXE Transcription Factors-SOX8, SOX9 and SOX10-share a Bi-partite Transactivation Mechanism

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2019 Jun 14

PMID 31194875

Citations 25

Authors

Abdul Haseeb

Veronique Lefebvre

Affiliations

Soon will be listed here.

Abstract

SOX8, SOX9 and SOX10 compose the SOXE transcription factor group. They govern cell fate and differentiation in many lineages, and mutations impairing their activity cause severe diseases, including campomelic dysplasia (SOX9), sex determination disorders (SOX8 and SOX9) and Waardenburg-Shah syndrome (SOX10). However, incomplete knowledge of their modes of action limits disease understanding. We here uncover that the proteins share a bipartite transactivation mechanism, whereby a transactivation domain in the middle of the proteins (TAM) synergizes with a C-terminal one (TAC). TAM comprises amphipathic α-helices predicted to form a protein-binding pocket and overlapping with minimal transactivation motifs (9-aa-TAD) described in many transcription factors. One 9-aa-TAD sequence includes an evolutionarily conserved and functionally required EΦ[D/E]QYΦ motif. SOXF proteins (SOX7, SOX17 and SOX18) contain an identical motif, suggesting evolution from a common ancestor already harboring this motif, whereas TAC and other transactivating SOX proteins feature only remotely related motifs. Missense variants in this SOXE/SOXF-specific motif are rare in control individuals, but have been detected in cancers, supporting its importance in development and physiology. By deepening understanding of mechanisms underlying the central transactivation function of SOXE proteins, these findings should help further decipher molecular networks essential for development and health and dysregulated in diseases.

Citing Articles

SOX9: a key transcriptional regulator in organ fibrosis.

Li Y, Xing Y, Liu N, Liu B, Wang Z Front Pharmacol. 2025; 16:1507282.

PMID: 39974732 PMC: 11835943. DOI: 10.3389/fphar.2025.1507282.

Sox8: a multifaceted transcription factor in development and disease.

Gonzalez Alvarado M, Aprato J Biol Open. 2025; 14(2).

PMID: 39936824 PMC: 11849977. DOI: 10.1242/bio.061840.

Variants in the SOX9 transactivation middle domain induce axial skeleton dysplasia and scoliosis.

Wang L, Liu Z, Zhao S, Xu K, Aceves V, Qiu C Proc Natl Acad Sci U S A. 2025; 122(4):e2313978121.

PMID: 39854231 PMC: 11789016. DOI: 10.1073/pnas.2313978121.

Missense variants weakening a SOX9 phosphodegron linked to odontogenesis defects, scoliosis, and other skeletal features.

Ettaki I, Haseeb A, Karvande A, Amalou G, Saih A, AitRaise I HGG Adv. 2025; 6(2):100404.

PMID: 39797402 PMC: 11834033. DOI: 10.1016/j.xhgg.2025.100404.

Unveiling the roles of Sertoli cells lineage differentiation in reproductive development and disorders: a review.

Gao Y, Wang Z, Long Y, Yang L, Jiang Y, Ding D Front Endocrinol (Lausanne). 2024; 15:1357594.

PMID: 38699384 PMC: 11063913. DOI: 10.3389/fendo.2024.1357594.

References

Takash W, Canizares J, Bonneaud N, Poulat F, Mattei M, Jay P . SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res. 2001; 29(21):4274-83. PMC: 60197. DOI: 10.1093/nar/29.21.4274. View

Frietze S, Farnham P . Transcription factor effector domains. Subcell Biochem. 2011; 52:261-77. PMC: 4151296. DOI: 10.1007/978-90-481-9069-0_12. View

Jo A, Denduluri S, Zhang B, Wang Z, Yin L, Yan Z . The versatile functions of Sox9 in development, stem cells, and human diseases. Genes Dis. 2015; 1(2):149-161. PMC: 4326072. DOI: 10.1016/j.gendis.2014.09.004. View

Lefebvre V, Huang W, Harley V, Goodfellow P, de Crombrugghe B . SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol. 1997; 17(4):2336-46. PMC: 232082. DOI: 10.1128/MCB.17.4.2336. View

Tsuda M, Takahashi S, Takahashi Y, Asahara H . Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem. 2003; 278(29):27224-9. DOI: 10.1074/jbc.M303471200. View

Veeman M, Slusarski D, Kaykas A, Louie S, Moon R . Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr Biol. 2003; 13(8):680-5. DOI: 10.1016/s0960-9822(03)00240-9. View

Bienert S, Waterhouse A, de Beer T, Tauriello G, Studer G, Bordoli L . The SWISS-MODEL Repository-new features and functionality. Nucleic Acids Res. 2016; 45(D1):D313-D319. PMC: 5210589. DOI: 10.1093/nar/gkw1132. View

Piskacek M, Vasku A, Hajek R, Knight A . Shared structural features of the 9aaTAD family in complex with CBP. Mol Biosyst. 2015; 11(3):844-51. DOI: 10.1039/c4mb00672k. View

Atsumi T, Miwa Y, Kimata K, Ikawa Y . A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev. 1990; 30(2):109-16. DOI: 10.1016/0922-3371(90)90079-c. View

10.

Barrionuevo F, Scherer G . SOX E genes: SOX9 and SOX8 in mammalian testis development. Int J Biochem Cell Biol. 2009; 42(3):433-6. DOI: 10.1016/j.biocel.2009.07.015. View

11.

Aksoy I, Jauch R, Eras V, Chng W, Chen J, Divakar U . Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming. Stem Cells. 2013; 31(12):2632-46. DOI: 10.1002/stem.1522. View

12.

Valenzuela I, Fernandez-Alvarez P, Plaja A, Ariceta G, Sabate-Rotes A, Garcia-Arumi E . Further delineation of the SOX18-related Hypotrichosis, Lymphedema, Telangiectasia syndrome (HTLS). Eur J Med Genet. 2018; 61(5):269-272. DOI: 10.1016/j.ejmg.2018.01.001. View

13.

Zhou R, Bonneaud N, Yuan C, de Santa Barbara P, Boizet B, Schomber T . SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic Acids Res. 2002; 30(14):3245-52. PMC: 135763. DOI: 10.1093/nar/gkf443. View

14.

Klum S, Zaouter C, Alekseenko Z, Bjorklund A, Hagey D, Ericson J . Sequentially acting SOX proteins orchestrate astrocyte- and oligodendrocyte-specific gene expression. EMBO Rep. 2018; 19(11). PMC: 6216240. DOI: 10.15252/embr.201846635. View

15.

Reiprich S, Wegner M . From CNS stem cells to neurons and glia: Sox for everyone. Cell Tissue Res. 2014; 359(1):111-24. DOI: 10.1007/s00441-014-1909-6. View

16.

Uesugi M, Verdine G . The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2. Proc Natl Acad Sci U S A. 1999; 96(26):14801-6. PMC: 24728. DOI: 10.1073/pnas.96.26.14801. View

17.

Han Y, Lefebvre V . L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol. 2008; 28(16):4999-5013. PMC: 2519711. DOI: 10.1128/MCB.00695-08. View

18.

Pfeifer D, Poulat F, Holinski-Feder E, Kooy F, Scherer G . The SOX8 gene is located within 700 kb of the tip of chromosome 16p and is deleted in a patient with ATR-16 syndrome. Genomics. 2000; 63(1):108-16. DOI: 10.1006/geno.1999.6060. View

19.

Sinner D, Rankin S, Lee M, Zorn A . Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development. 2004; 131(13):3069-80. DOI: 10.1242/dev.01176. View

20.

McDowall S, Argentaro A, Ranganathan S, Weller P, Mertin S, Mansour S . Functional and structural studies of wild type SOX9 and mutations causing campomelic dysplasia. J Biol Chem. 1999; 274(34):24023-30. DOI: 10.1074/jbc.274.34.24023. View